HC Deb 02 May 2002 vol 384 c1008W
Dr. Fox

To ask the Secretary of State for Health what the commercial basis of the decision to award the anti-TB vaccination contract to Powderject was. [38678]

Yvette Cooper

[holding answer 28 February 2002]: The contract was awarded to Powderject under European Union public procurement regulations.

Powderject was the only manufacturer with a United Kingdom licence to supply BCG vaccine at that time.